mocetinostat and Influenza--Human

Topics: Coinfection; Communicable Diseases; Humans; Influenza, Human; Lung; Neutrophils; Orthomyxoviridae; Orthomyxoviridae Infections; Peroxidase; Pseudomonas aeruginosa; Pseudomonas Infections

High levels of circulating neutrophil extracellular traps (NETs) are associated with a poor prognosis in influenza A infection. It remains unclear whether NETs in the plasma or bronchoalveolar lavage fluid (BALF) can predict clinical outcomes in influenza.. One hundred eighteen patients who were diagnosed with H1N1 influenza in 2017-2018 were recruited. The NETs were assessed in plasma and BALF samples by quantifying cell-free deoxyribonucleic acid (cfDNA) and protein-DNA complexes. Predictions of severe illness and 60-day mortality were analyzed with receiver operating characteristic curves.. The NET levels were significantly elevated in the BALF and contributed to the pathology of lungs, yet it was not associated with disease severity or mortality in patients severely infected with H1N1. Plasma NET levels were significantly increased in the patients with severe influenza and positively correlated with the oxygen index and sequential organ failure assessment scores. High levels of plasma cfDNA (>286.6 ng/mL) or histone-bound DNA (>9.4 ng/mL) discriminated severe influenza from mild, and even higher levels of cfDNA (>306.3 ng/mL) or histone-bound DNA (>23.1 ng/mL) predicted fatal outcomes in severely ill patients.. The cfDNA and histone-bound DNA in plasma represent early predictive biomarkers for the prognosis of influenza.

Topics: Adult; Aged; Alveolar Epithelial Cells; Biomarkers; Bronchoalveolar Lavage Fluid; Case-Control Studies; Cell-Free Nucleic Acids; Cells, Cultured; Extracellular Traps; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung; Male; Middle Aged; Organ Dysfunction Scores; Permeability; Peroxidase; Plasma; Prognosis; ROC Curve; Severity of Illness Index; Young Adult

Influenza poses a severe threat to human health in the world. However, developing a universal anti-viral strategy has remained challenging due to the presence of diverse subtypes as well as its high mutation rate, resulting in antigenic shift and drift. Here we developed an antiviral strategy using iron oxide nanozymes (IONzymes) to target the lipid envelope of the influenza virus.

Topics: Animals; Antiviral Agents; Biocatalysis; Female; Ferric Compounds; Humans; Influenza A virus; Influenza, Human; Lipid Peroxidation; Membrane Lipids; Mice, Inbred BALB C; Peroxidase

Most patients with severe infection with influenza A virus (IAV) progress to acute respiratory distress syndrome and even multiple organ dysfunction syndrome (MODS). Neutrophil extracellular traps (NETs) can be induced by pathogens and are responsible for immune tissue damage. We conducted a prospective study on the production and effects of NETs in H7N9 and H1N1 patients.. We investigated NET production in plasma and supernatant of cultured neutrophils by measuring cell-free deoxyribonucleic acid (DNA) and myeloperoxidase (MPO)-DNA complexes with PicoGreen dye and enzyme-linked immunosorbent assay methods, respectively. We also observed NET structure by immunofluorescence staining.. We found that patients with severe influenza showed elevated plasma NET level on the day of admission. Neutrophils from these patients showed higher capacity to release MPO-DNA complex in response to interleukin-8 or lipopolysaccharide stimulation. We also found that NETs from H7N9 and H1N1 patients increased the permeability of alveolar epithelial cells, and, consequently, NET production was positively correlated with acute physiology and chronic health evaluation (APACHE) II score and MODS.. These data indicate that high level of NETs contributes to lung injury and is correlated with severity of disease. Thus, NETs might be a key factor to predict the poor prognosis in IAV patients.

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Epithelial Cells; Cells, Cultured; Child; Child, Preschool; DNA; Enzyme-Linked Immunosorbent Assay; Extracellular Traps; Female; Fluorescent Antibody Technique; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H7N9 Subtype; Influenza, Human; Lung; Male; Middle Aged; Permeability; Peroxidase; Plasma; Prognosis; Prospective Studies; Staining and Labeling; Young Adult

Multifunctional nanohybrids have created new and valuable opportunities for a wide range of catalysis and biotechnology applications. Here, we present a relatively simple method for producing nanohybrids composed of gold nanoparticles (Au NPs) and carbon nanotubes (CNTs) that does not require an acidic pre-treatment of the CNTs. Transmission electron microscopy (TEM) images and ultraviolet-visible (UV-vis) spectra revealed that Au NPs bonded to the CNT surface. Surface-enhanced Raman scattering (SERS) revealed a stronger signal from Au-CNT nanohybrids than from pristine CNTs. The Au-CNT nanohybrids showed catalytic activity in the oxidation of 3, 3', 5, 5'-tetramethyl-benzidine (TMB) by H2O2 and developed a unique blue colour in aqueous solution. Because of the enhanced peroxidase-like activity of these Au-CNT nanohybrids, they were selected for use as part of a highly sensitive colorimetric test for influenza virus A (H3N2). In the presence of influenza A virus (H3N2) in the test system (specific antibody-conjugated Au CNT nanohybrids-TMB-H2O2), a deep blue colour developed, the optical density of which was dependent on the virus concentration (10-50,000 PFU/ml). The limit of detection of this proposed method was 3.4 PFU/ml, a limit 385 times lower than that of conventional ELISA (1312 PFU/ml). The sensitivity of this test was also 500 times greater than that of commercial immunochromatography kits. The nanohybrid preparation and colorimetric detection methods reported herein may be easily adapted to other nanohybrid structures with enzyme mimetic properties for broader applications in catalysis and nanobiotechnology.

Topics: Antibodies, Immobilized; Benzidines; Biosensing Techniques; Catalysis; Colorimetry; Gold; Humans; Hydrogen Peroxide; Influenza A Virus, H3N2 Subtype; Influenza, Human; Limit of Detection; Metal Nanoparticles; Nanotubes, Carbon; Peroxidase; Spectrum Analysis, Raman

Parenchymal lung inflammation and airway and alveolar epithelial cell apoptosis are associated with cigarette smoke exposure (CSE), which contributes to chronic obstructive pulmonary disease (COPD). Epidemiological studies indicate that people exposed to chronic cigarette smoke with or without COPD are more susceptible to influenza A virus (IAV) infection. We found increased p53, PAI-1 and apoptosis in AECs, with accumulation of macrophages and neutrophils in the lungs of patients with COPD. In Wild-type (WT) mice with passive CSE (PCSE), p53 and PAI-1 expression and apoptosis were increased in AECs as was lung inflammation, while those lacking p53 or PAI-1 resisted AEC apoptosis and lung inflammation. Further, inhibition of p53-mediated induction of PAI-1 by treatment of WT mice with caveolin-1 scaffolding domain peptide (CSP) reduced PCSE-induced lung inflammation and reversed PCSE-induced suppression of eosinophil-associated RNase1 (EAR1). Competitive inhibition of the p53-PAI-1 mRNA interaction by expressing p53-binding 3'UTR sequences of PAI-1 mRNA likewise suppressed CS-induced PAI-1 and AEC apoptosis and restored EAR1 expression. Consistent with PCSE-induced lung injury, IAV infection increased p53, PAI-1 and apoptosis in AECs in association with pulmonary inflammation. Lung inflammation induced by PCSE was worsened by subsequent exposure to IAV. Mice lacking PAI-1 that were exposed to IAV showed minimal viral burden based on M2 antigen and hemagglutination analyses, whereas transgenic mice that overexpress PAI-1 without PCSE showed increased M2 antigen and inflammation after IAV infection. These observations indicate that increased PAI-1 expression promotes AEC apoptosis and exacerbates lung inflammation induced by IAV following PCSE.

Topics: Alveolar Epithelial Cells; Animals; Apoptosis; Caveolin 1; Humans; Influenza A virus; Influenza, Human; Leukocyte Elastase; Luciferases; Lung; Lung Injury; Mice, Inbred C57BL; Orthomyxoviridae Infections; Peptide Fragments; Peroxidase; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Pulmonary Disease, Chronic Obstructive; Smoking; Tumor Suppressor Protein p53

Severe respiratory disease arising from influenza virus infection has a high fatality rate. Neutrophil myeloperoxidase (MPO) has been implicated in the pathogenesis of severe influenza-induced pneumonia because extracellularly released MPO mediates the production of hypochlorous acid, a potent tissue injury factor. To search for candidate anti-influenza compounds, we screened leucomycin A3 (LM-A3), spiramycin (SPM), an erythromycin derivative (EM900, in which anti-bacterial activity has been eliminated), and clarithromycin (CAM), by analyzing their ability to inhibit MPO release in neutrophils from mice and humans. When each candidate was injected into mice infected with a lethal dose of A/H1N1 influenza virus (PR-8), LM-A3 produced the highest survival rate (80.9%). We found that LM-A3 induced beneficial effects on lung pathology and viral proliferation involved in the regulatory activity of MPO release, pro-inflammatory cytokines and interferon-α production in the lung. SPM and EM900 also induced positive survival effects in the infected mice, whereas CAM did not. We further found that these compounds inhibit virus proliferation in human pneumonia epithelial A549 cells in vitro. LM-A3 showed effective action against influenza A virus infection with high anti-viral activity in human host cells, indicating the possibility that LM-A3 is a prospective lead compound for the development of a drug for human influenza. The positive survival effect induced by EM900 suggests that pharmacological architectures between anti-bacterial and anti-influenza virus activities can be dissociated in macrolide derivatives. These observations provide valuable evidence for the potential development of novel macrolide derivatives that have strong anti-viral but no anti-bacterial activity.

Topics: Animals; Antiviral Agents; Cell Line, Tumor; Clarithromycin; Cytokines; Disease Models, Animal; Disease Progression; Drug Design; Epithelial Cells; Erythromycin; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Josamycin; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Spiramycin; Survival Rate

The antioxidant N-acetyl-l-cysteine (NAC) had been shown to inhibit replication of seasonal human influenza A viruses. Here, the effects of NAC on H9N2 swine influenza virus-induced acute lung injury (ALI) were investigated in mice. BALB/c mice were inoculated intranasally with 10(7) 50% tissue culture infective doses (TCID(50)) of A/swine/HeBei/012/2008/(H9N2) viruses with or without NAC treatments to induce ALI model. The result showed that pulmonary inflammation, pulmonary edema, MPO activity, total cells, neutrophils, macrophages, TNF-α, IL-6, IL-1β and CXCL-10 in BALF were attenuated by NAC. Moreover, our data showed that NAC significantly inhibited the levels of TLR4 protein and TLR4 mRNA in the lungs. Pharmacological inhibitors of TLR4 (E5564) exerted similar effects like those determined for NAC in H9N2 swine influenza virus-infected mice. These results suggest that antioxidants like NAC represent a potential additional treatment option that could be considered in the case of an influenza A virus pandemic.

Topics: Acetylcysteine; Acute Lung Injury; Animals; Antioxidants; Cytokines; Disease Models, Animal; Humans; Inflammation Mediators; Influenza A Virus, H9N2 Subtype; Influenza, Human; Lipid A; Lung; Male; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Peroxidase; Swine; Toll-Like Receptor 4; Virus Replication

Highly pathogenic avian H5N1 influenza virus (H5N1) infection in humans causes acute respiratory distress syndrome, leading to multiple organ failure. Five fatal cases of H5N1 infection in Vietnam were analyzed pathologically to reveal virus distribution, and local proinflammatory cytokine and chemokine expression profiles in formalin-fixed, paraffin-embedded lung tissues. Our main histopathological findings showed diffuse alveolar damage in the lungs. The infiltration of myeloperoxidase-positive and/or CD68 (clone KP-1)-positive neutrophils and monocytes/macrophages was remarkable in the alveolar septa and alveolar spaces. Immunohistochemistry revealed that H5N1 mainly infected alveolar epithelial cells and monocytes/macrophages in lungs. H5N1 replication was confirmed by detecting H5N1 mRNA in epithelial cells using in situ hybridization. Quantitation of H5N1 RNA using quantitative reverse transcription PCR assays revealed that the level of H5N1 RNA was increased in cases during early phases of the disease. We quantified the expression of tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, IL-8, regulated on activation normal T-cell expressed and secreted (commonly known as RANTES), and interferon-gamma-inducible protein of 10 kDa (IP-10) in formalin-fixed, paraffin-embedded lung sections. Their expression levels correlated with H5N1 RNA copy numbers detected in the same lung region. Double immunofluorescence staining revealed that TNF-α, IL-6, IL-8 and IP-10 were expressed in epithelial cells and/or monocytes/macrophages. In particular, IL-6 was also expressed in endothelial cells. The dissemination of H5N1 beyond respiratory organs was not confirmed in two cases examined in this study.

Topics: Alveolar Epithelial Cells; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Chemokines; Child; Child, Preschool; Cytokines; Fatal Outcome; Female; Fixatives; Fluorescent Antibody Technique; Formaldehyde; Humans; Immunohistochemistry; In Situ Hybridization; Inflammation Mediators; Influenza A Virus, H5N1 Subtype; Influenza, Human; Lung; Macrophages; Male; Neutrophils; Paraffin Embedding; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Viral; Tissue Fixation; Vietnam; Viral Load

Topics: Child; Cytokines; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Interleukin-12; Peroxidase; Prognosis; Respiratory Distress Syndrome; Vietnam

Influenza virus infection causes severe respiratory disease such as that due to avian influenza (H5N1). Influenza A viruses proliferate in human epithelial cells, which produce inflammatory cytokines/chemokines as a "cytokine storm" attenuated with the viral nonstructural protein 1 (NS1). Cytokine/chemokine production in A549 epithelial cells infected with influenza A/H1N1 virus (PR-8) or nonstructural protein 1 (NS1) plasmid was examined in vitro. Because tumor necrosis factor-α (TNF-α) and regulated upon activation normal T-cell expressed and secreted (RANTES) are predominantly produced from cells infected with PR-8 virus, the effects of mRNA knockdown of these cytokines were investigated. Small interfering (si)TNF-α down-regulated RANTES expression and secretion of RANTES, interleukin (IL)-8, and monocyte chemotactic protein-1 (MCP-1). In addition, siRANTES suppressed interferon (IFN)-γ expression and secretion of RANTES, IL-8, and MCP-1, suggesting that TNF-α stimulates production of RANTES, IL-8, MCP-1, and IFN-γ, and RANTES also increased IL-8, MCP-1, and IFN-γ. Furthermore, administration of TNF-α promoted increased secretion of RANTES, IL-8, and MCP-1. Administration of RANTES enhanced IL-6, IL-8, and MCP-1 production without PR-8 infection. These results strongly suggest that, as an initial step, TNF-α regulates RANTES production, followed by increase of IL-6, IL-8, and MCP-1 and IFNs concentrations. At a later stage, cells transfected with viral NS1 plasmid showed production of a large amount of IL-8 and MCP-1 in the presence of the H(2)O(2)-myeloperoxidse (MPO) system, suggesting that NS1 of PR-8 may induce a "cytokine storm" from epithelial cells in the presence of an H(2)O(2)-MPO system.

Topics: Cell Line; Cell Proliferation; Cell Survival; Chemokine CCL5; Chemokines; Cytokines; Down-Regulation; Epithelial Cells; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphocyte Activation; Neutrophils; Peroxidase; Recombinant Proteins; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Viral Nonstructural Proteins

Acute lung injury due to influenza infection is associated with high mortality, an increase in neutrophils in the airspace, and increases in tissue myeloperoxidase (MPO). Because IL-17A and IL-17F, ligands for IL-17 receptor antagonist (IL-17RA), have been shown to mediate neutrophil migration into the lung in response to LPS or Gram-negative bacterial pneumonia, we hypothesized that IL-17RA signaling was critical for acute lung injury in response to pulmonary influenza infection. IL-17RA was critical for weight loss and both neutrophil migration and increases in tissue myeloperoxidase (MPO) after influenza infection. However, IL-17RA was dispensable for the recruitment of CD8(+) T cells specific for influenza hemagglutinin or nucleocapsid protein. Consistent with this, IL-17RA was not required for viral clearance. However, in the setting of influenza infection, IL-17RA(-/-) mice showed significantly reduced levels of oxidized phospholipids, which have previously been shown to be an important mediator in several models of acute lung injury, including influenza infection and gastric acid aspiration. Taken together, these data support targeting IL-17 or IL-17RA in acute lung injury due to acute viral infection.

Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; CD8-Positive T-Lymphocytes; Cell Movement; Disease Models, Animal; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interleukin-17; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Peroxidase; Receptors, Interleukin-17; Signal Transduction; Tumor Necrosis Factor-alpha

Topics: Disease Progression; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Neutrophils; Peroxidase; Virus Inactivation; Young Adult

In children, the incidence of complicated pneumonias (including empyemas and lung abscesses) associated with Streptococcus pneumoniae infection has increased in recent years. In many cases, these complicated pneumonias followed flu-like illnesses. To determine mechanisms behind this association, a murine model of sequential pulmonary infection has been developed. BALB/cJ mice infected with influenza A had mild pulmonary inflammation that resolved within 5-7 days. Seven days following their initial 'treatment' (mock infection or influenza exposure), mice were challenged with 10(6) cfu of S. pneumoniae, and their lungs were harvested at intervals for analysis. Lungs of influenza-exposed mice demonstrated greater colony counts 24 and 48 h following S. pneumoniae exposure compared to control mice. In addition, neutrophil numbers were significantly increased in the influenza/S. pneumoniae sequentially-infected animals compared to S. pneumoniae infection alone (1.4+/-0.6 x 10(6) vs. 0.06+/-0.07 x 10(6) cells, P < 0.05, 24 h). Influenza-exposed animals had greater levels of IL-1beta and TNF-alpha in lung homogenates following S. pneumoniae inoculation. These data demonstrate that mice exposed to influenza have enhanced inflammatory responses and increased bacterial burden following S. pneumoniae exposure than do control mice. This model will be useful in defining mechanisms behind the enhanced susceptibility to S. pneumoniae that occurs after influenza exposure.

Topics: Animals; Disease Models, Animal; Disease Susceptibility; Humans; Influenza A virus; Influenza, Human; Interleukin-1; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Pneumococcal Infections; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha

Topics: Abscess; Animals; Bronchopneumonia; Brucellosis; Cellulitis; Clinical Enzyme Tests; Communicable Diseases; Furunculosis; Herpes Zoster; Humans; Infections; Influenza, Human; Leukocytes; Oxidoreductases; Peroxidase; Peroxidases; Pneumonia; Pyoderma; Tinea